Skip to content

Clinical trials

Mastocytosis, Systemic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mastocytosis, Systemic Country / region: Italy Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20152
20181
20191
20201
20212
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation4
Cogent Biosciences, Inc.2
Deciphera Pharmaceuticals, LLC1
Federico II University1
Fondazione IRCCS Policlinico San Matteo di Pavia1
Novartis Pharmaceuticals1
Patara Pharma1
Telios Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mastocytosis, Systemic12
Leukemia, Mast-Cell3
Mastocytosis3
Hematologic Diseases2
Hypersensitivity2
Immune Complex Diseases2
Immune System Diseases2
Carcinoma, Non-Small-Cell Lung1
Gastrointestinal Stromal Tumors1
Glioma1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.